Network-based in silico drug efficacy screening
Open Access
- 1 February 2016
- journal article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 7 (1), 10331
- https://doi.org/10.1038/ncomms10331
Abstract
The increasing cost of drug development together with a significant drop in the number of new drug approvals raises the need for innovative approaches for target identification and efficacy prediction. Here, we take advantage of our increasing understanding of the network-based origins of diseases to introduce a drug-disease proximity measure that quantifies the interplay between drugs targets and diseases. By correcting for the known biases of the interactome, proximity helps us uncover the therapeutic effect of drugs, as well as to distinguish palliative from effective treatments. Our analysis of 238 drugs used in 78 diseases indicates that the therapeutic effect of drugs is localized in a small network neighborhood of the disease genes and highlights efficacy issues for drugs used in Parkinson and several inflammatory disorders. Finally, network-based proximity allows us to predict novel drug-disease associations that offer unprecedented opportunities for drug repurposing and the detection of adverse effects.Keywords
This publication has 50 references indexed in Scilit:
- Systematic identification of proteins that elicit drug side effectsMolecular Systems Biology, 2013
- DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression dataBioinformatics, 2012
- Metab2MeSH: annotating compounds with medical subject headingsBioinformatics, 2012
- PREDICT: a method for inferring novel drug indications with application to personalized medicineMolecular Systems Biology, 2011
- Network medicine: a network-based approach to human diseaseNature Reviews Genetics, 2010
- How does diabetes accelerate Alzheimer disease pathology?Nature Reviews Neurology, 2010
- Network analyses in systems pharmacologyBioinformatics, 2009
- Potential etiologic and functional implications of genome-wide association loci for human diseases and traitsProceedings of the National Academy of Sciences, 2009
- The human disease networkProceedings of the National Academy of Sciences, 2007
- Global reconstruction of the human metabolic network based on genomic and bibliomic dataProceedings of the National Academy of Sciences of the United States of America, 2007